Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase

ACS Infectious Diseases

Volumn 1, Issue 3, 2015, Pages 140-148

  Sweeney, Noreena L ^a   Hanson, Alicia M ^a   Mukherjee, Sourav ^a   Ndjomou, Jean ^a   Geiss, Brian J ^b   Steel, J Jordan ^b   Frankowski, Kevin J ^c   Li, Kelin ^c   Schoenen, Frank J ^c   Frick, David N ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

ATPase; Dengue fever; direct acting antiviral; motor protein; nonstructural protein 3; positive sense single stranded RNA ((+)ssRNA) virus; West Nile virus; yellow fever virus

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATE; ANTIVIRUS AGENT; AURINTRICARBOXYLIC ACID; BENZOTHIAZOLE; DIMETHYL SULFOXIDE; FLAVIVIRUS HELICASE INHIBITOR; HELICASE; NONSTRUCTURAL PROTEIN 3; POLYURIDYLIC ACID; RENILLA LUCIFERIN 2 MONOOXYGENASE; SURAMIN; THIOREDOXIN; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS RNA;

ARTICLE; ASSAY; ATPASE ACTIVITY ASSAY; CATALYSIS; CELL VIABILITY; CELL VIABILITY ASSAY; COLORIMETRY; DENGUE VIRUS; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HYDROLYSIS; IC50; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PRIORITY JOURNAL; REPLICON ASSAY; REPLICON CELL; RNA BINDING; VIRUS REPLICATION; WEST NILE VIRUS;

EID: 84969213558     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/id5000458     Document Type: Article

References (57)

1. Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., Myers, M. F., George, D. B., Jaenisch, T., Wint, G. R., Simmons, C. P., Scott, T. W., Farrar, J. J., and Hay, S. I. (2013) The global distribution and burden of dengue Nature 496, 504-507 10.1038/nature12060
2. Lim, S. P., Wang, Q. Y., Noble, C. G., Chen, Y. L., Dong, H., Zou, B., Yokokawa, F., Nilar, S., Smith, P., Beer, D., Lescar, J., and Shi, P. Y. (2013) Ten years of dengue drug discovery: progress and prospects Antiviral Res. 100, 500-519 10.1016/j.antiviral.2013.09.013
3. Scaturro, P., Trist, I. M., Paul, D., Kumar, A., Acosta, E. G., Byrd, C. M., Jordan, R., Brancale, A., and Bartenschlager, R. (2014) Characterization of the mode of action of a potent dengue virus capsid inhibitor J. Virol. 88, 11540-11555 10.1128/JVI.01745-14
4. Niyomrattanakit, P., Chen, Y. L., Dong, H., Yin, Z., Qing, M., Glickman, J. F., Lin, K., Mueller, D., Voshol, H., Lim, J. Y., Nilar, S., Keller, T. H., and Shi, P. Y. (2010) Inhibition of dengue virus polymerase by blocking of the RNA tunnel J. Virol. 84, 5678-5686 10.1128/JVI.02451-09
5. Tomlinson, S. M. and Watowich, S. J. (2011) Anthracene-based inhibitors of dengue virus NS2B-NS3 protease Antiviral Res. 89, 127-135 10.1016/j.antiviral.2010.12.006
6. Deng, J., Li, N., Liu, H., Zuo, Z., Liew, O. W., Xu, W., Chen, G., Tong, X., Tang, W., Zhu, J., Zuo, J., Jiang, H., Yang, C. G., Li, J., and Zhu, W. (2012) Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping J. Med. Chem. 55, 6278-6293 10.1021/jm300146f
7. Xie, X., Wang, Q. Y., Xu, H. Y., Qing, M., Kramer, L., Yuan, Z., and Shi, P. Y. (2011) Inhibition of dengue virus by targeting viral NS4B protein J. Virol. 85, 11183-11195 10.1128/JVI.05468-11
8. Stahla-Beek, H. J., April, D. G., Saeedi, B. J., Hannah, A. M., Keenan, S. M., and Geiss, B. J. (2012) Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme J. Virol. 86, 8730-8739 10.1128/JVI.00384-12
9. De Clercq, E. (2014) Current race in the development of DAAs (direct-acting antivirals) against HCV Biochem. Pharmacol. 10.1016/j.bcp.2014.04.005
10. Frick, D. N. (2007) The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target Curr. Issues Mol. Biol. 9, 1-20
11. Mukherjee, S., Hanson, A. M., Shadrick, W. R., Ndjomou, J., Sweeney, N. L., Hernandez, J. J., Bartczak, D., Li, K., Frankowski, K. J., Heck, J. A., Arnold, L. A., Schoenen, F. J., and Frick, D. N. (2012) Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays Nucleic Acids Res. 40, 8607-8621 10.1093/nar/gks623
12. Ndjomou, J., Kolli, R., Mukherjee, S., Shadrick, W. R., Hanson, A. M., Sweeney, N. L., Bartczak, D., Li, K., Frankowski, K. J., Schoenen, F. J., and Frick, D. N. (2012) Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation Antiviral Res. 96, 245-255 10.1016/j.antiviral.2012.08.006
13. Mukherjee, S., Weiner, W. S., Schroeder, C. E., Simpson, D. S., Hanson, A. M., Sweeney, N. L., Marvin, R. K., Ndjomou, J., Kolli, R., Isailovic, D., Schoenen, F. J., and Frick, D. N. (2014) Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication ACS Chem. Biol. 9, 2393-2403 10.1021/cb500512z
14. Saalau-Bethell, S. M., Woodhead, A. J., Chessari, G., Carr, M. G., Coyle, J., Graham, B., Hiscock, S. D., Murray, C. W., Pathuri, P., Rich, S. J., Richardson, C. J., Williams, P. A., and Jhoti, H. (2012) Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function Nat. Chem. Biol. 8, 920-925 10.1038/nchembio.1081
15. Luo, D., Xu, T., Watson, R. P., Scherer-Becker, D., Sampath, A., Jahnke, W., Yeong, S. S., Wang, C. H., Lim, S. P., Strongin, A., Vasudevan, S. G., and Lescar, J. (2008) Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein EMBO J. 27, 3209-3219 10.1038/emboj.2008.232
16. Gu, M. and Rice, C. M. (2010) Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism Proc. Natl. Acad. Sci. U.S.A. 107, 521-528 10.1073/pnas.0913380107
17. Tomei, L., Failla, C., Santolini, E., De Francesco, R., and La Monica, N. (1993) NS3 is a serine protease required for processing of hepatitis C virus polyprotein J. Virol. 67, 4017-4026
18. Yao, N., Reichert, P., Taremi, S. S., Prosise, W. W., and Weber, P. C. (1999) Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase Structure 7, 1353-1363 10.1016/S0969-2126(00)80025-8
19. Luo, D., Xu, T., Hunke, C., Gruber, G., Vasudevan, S. G., and Lescar, J. (2008) Crystal structure of the NS3 protease-helicase from dengue virus J. Virol. 82, 173-183 10.1128/JVI.01788-07
20. Assenberg, R., Mastrangelo, E., Walter, T. S., Verma, A., Milani, M., Owens, R. J., Stuart, D. I., Grimes, J. M., and Mancini, E. J. (2009) Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication J. Virol. 83, 12895-12906 10.1128/JVI.00942-09
21. Erbel, P., Schiering, N., D'Arcy, A., Renatus, M., Kroemer, M., Lim, S. P., Yin, Z., Keller, T. H., Vasudevan, S. G., and Hommel, U. (2006) Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus Nat. Struct Mol. Biol. 13, 372-373 10.1038/nsmb1073
22. Aleshin, A. E., Shiryaev, S. A., Strongin, A. Y., and Liddington, R. C. (2007) Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold Protein Sci. 16, 795-806 10.1110/ps.072753207
23. Aydin, C., Mukherjee, S., Hanson, A. M., Frick, D. N., and Schiffer, C. A. (2013) The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities Protein Sci. 22, 1786-1798 10.1002/pro.2378
24. Luo, D., Wei, N., Doan, D. N., Paradkar, P. N., Chong, Y., Davidson, A. D., Kotaka, M., Lescar, J., and Vasudevan, S. G. (2010) Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications J. Biol. Chem. 285, 18817-18827 10.1074/jbc.M109.090936
25. 2+-dependent and require a functional Walker B motif in the helicase catalytic core Virology 328, 208-218 10.1016/j.virol.2004.07.004
26. Wu, J., Bera, A. K., Kuhn, R. J., and Smith, J. L. (2005) Structure of the flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing J. Virol. 79, 10268-10277 10.1128/JVI.79.16.10268-10277.2005
27. Borowski, P., Niebuhr, A., Schmitz, H., Hosmane, R. S., Bretner, M., Siwecka, M. A., and Kulikowski, T. (2002) NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme Acta Biochim. Polym. 49, 597-614 10.1002/actp.1988.010391017
28. Mastrangelo, E., Pezzullo, M., De Burghgraeve, T., Kaptein, S., Pastorino, B., Dallmeier, K., de Lamballerie, X., Neyts, J., Hanson, A. M., Frick, D. N., Bolognesi, M., and Milani, M. (2012) Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug J. Antimicrob. Chemother. 67, 1884-1894 10.1093/jac/dks147
29. Byrd, C. M., Grosenbach, D. W., Berhanu, A., Dai, D., Jones, K. F., Cardwell, K. B., Schneider, C., Yang, G., Tyavanagimatt, S., Harver, C., Wineinger, K. A., Page, J., Stavale, E., Stone, M. A., Fuller, K. P., Lovejoy, C., Leeds, J. M., Hruby, D. E., and Jordan, R. (2013) Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase Antimicrob. Agents Chemother. 57, 1902-1912 10.1128/AAC.02251-12
30. Basavannacharya, C. and Vasudevan, S. G. (2014) Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format Biochem. Biophys. Res. Commun. 10.1016/j.bbrc.2014.09.113
31. Li, K., Frankowski, K. J., Hanson, A. M., Ndjomou, J., Shanahan, M. A., Mukherjee, S., Kolli, R., Shadrick, W. R., Sweeney, N. L., Belon, C. A., Neuenswander, B., Ferguson, J., Aube, J., Schoenen, F. J., Blagg, B. S. J., and Frick, D. N. (2011) Hepatitis C virus NS3 helicase inhibitor discovery Probe Reports from the NIH Molecular Libraries Program, available from http://www.ncbi.nlm.nih.gov/books/NBK143540/.
32. Xu, T., Sampath, A., Chao, A., Wen, D., Nanao, M., Chene, P., Vasudevan, S. G., and Lescar, J. (2005) Structure of the dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 Å J. Virol. 79, 10278-10288 10.1128/JVI.79.16.10278-10288.2005
33. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4, 67-73 10.1177/108705719900400206
34. Shadrick, W. R., Mukherjee, S., Hanson, A. M., Sweeney, N. L., and Frick, D. N. (2013) Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP Biochemistry 52, 6151-6159 10.1021/bi4006495
35. Sweeney, N. L., Shadrick, W. R., Mukherjee, S., Li, K., Frankowski, K. J., Schoenen, F. J., and Frick, D. N. (2013) Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis J. Biol. Chem. 288, 19949-19957 10.1074/jbc.M113.463166
36. Li, K., Frankowski, K. J., Belon, C. A., Neuenswander, B., Ndjomou, J., Hanson, A. M., Shanahan, M. A., Schoenen, F. J., Blagg, B. S., Aube, J., and Frick, D. N. (2012) Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline J. Med. Chem. 55, 3319-3330 10.1021/jm300021v
37. Hanson, A. M., Hernandez, J. J., Shadrick, W. R., and Frick, D. N. (2012) Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase Methods Enzymol. 511, 463-483 10.1016/B978-0-12-396546-2.00021-8
38. Lam, A. M., Rypma, R. S., and Frick, D. N. (2004) Enhanced nucleic acid binding to ATP-bound hepatitis C virus NS3 helicase at low pH activates RNA unwinding Nucleic Acids Res. 32, 4060-4070 10.1093/nar/gkh74310.1093/nar/gkh743
39. Ventura, G. T., Costa, E. C., Capaccia, A. M., and Mohana-Borges, R. (2014) pH-dependent conformational changes in the HCV NS3 protein modulate its ATPase and helicase activities PLoS One 9 e115941 10.1371/journal.pone.0115941
40. Bolton, E. E., Wang, Y., Thiessen, P. A., and Bryant, S. H. (2008) PubChem: integrated platform of small molecules and biological activities Annu. Rep. Comput. Chem. 4, 217-241 10.1016/S1574-1400(08)00012-1
41. Whitby, K., Pierson, T. C., Geiss, B., Lane, K., Engle, M., Zhou, Y., Doms, R. W., and Diamond, M. S. (2005) Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo J. Virol. 79, 8698-8706 10.1128/JVI.79.14.8698-8706.2005
42. Kleymann, G. (2004) Helicase primase: targeting the Achilles heel of herpes simplex viruses Antivir Chem. Chemother. 15, 135-140
43. Field, H. J. and Mickleburgh, I. (2013) The helicase-primase complex as a target for effective herpesvirus antivirals Adv. Exp. Med. Biol. 767, 145-159 10.1007/978-1-4614-5037-5-7
44. Crute, J. J., Grygon, C. A., Hargrave, K. D., Simoneau, B., Faucher, A. M., Bolger, G., Kibler, P., Liuzzi, M., and Cordingley, M. G. (2002) Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease Nat. Med. 8, 386-391 10.1038/nm0402-386
45. Kleymann, G., Fischer, R., Betz, U. A., Hendrix, M., Bender, W., Schneider, U., Handke, G., Eckenberg, P., Hewlett, G., Pevzner, V., Baumeister, J., Weber, O., Henninger, K., Keldenich, J., Jensen, A., Kolb, J., Bach, U., Popp, A., Maben, J., Frappa, I., Haebich, D., Lockhoff, O., and Rubsamen-Waigmann, H. (2002) New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease Nat. Med. 8, 392-398 10.1038/nm0402-392
46. Baumeister, J., Fischer, R., Eckenberg, P., Henninger, K., Ruebsamen-Waigmann, H., and Kleymann, G. (2007) Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease Antivir Chem. Chemother. 18, 35-48
47. Kaufman, H. E., Varnell, E. D., Gebhardt, B. M., Thompson, H. W., Atwal, E., Rubsamen-Waigmann, H., and Kleymann, G. (2008) Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection J. Ocul. Pharmacol. Ther 24, 34-42 10.1089/jop.2007.0084
48. Wald, A., Corey, L., Timmler, B., Magaret, A., Warren, T., Tyring, S., Johnston, C., Kriesel, J., Fife, K., Galitz, L., Stoelben, S., Huang, M. L., Selke, S., Stobernack, H. P., Ruebsamen-Schaeff, H., and Birkmann, A. (2014) Helicase-primase inhibitor pritelivir for HSV-2 infection N. Engl. J. Med. 370, 201-210 10.1056/NEJMoa1301150
49. Tyring, S., Wald, A., Zadeikis, N., Dhadda, S., Takenouchi, K., and Rorig, R. (2012) ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study J. Infect. Dis. 205, 1100-1110 10.1093/infdis/jis019
50. Katsumata, K., Weinberg, A., Chono, K., Takakura, S., Kontani, T., and Suzuki, H. (2012) Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor Antimicrob. Agents Chemother. 56, 3587-3591 10.1128/AAC.00133-12
51. Shadrick, W. R., Ndjomou, J., Kolli, R., Mukherjee, S., Hanson, A. M., and Frick, D. N. (2013) Discovering new medicines targeting helicases: challenges and recent progress J. Biomol. Screen. 18, 761-781 10.1177/1087057113482586
52. Simoni, R. D., Hill, R. L., and Vaughan, M. (2002) The determination of phosphorus and the discovery of phosphocreatine and ATP: the work of Fiske and SubbaRow J. Biol. Chem. 277, 21e
53. Lanzetta, P. A., Alvarez, L. J., Reinach, P. S., and Candia, O. A. (1979) An improved assay for nanomole amounts of inorganic phosphate Anal. Biochem. 100, 95-97 10.1016/0003-2697(79)90115-5
54. Frick, D. N., Banik, S., and Rypma, R. S. (2007) Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: magnesium provides a bridge for ATP to fuel unwinding J. Mol. Biol. 365, 1017-1032 10.1016/j.jmb.2006.10.023
55. Seguin, S. P., Evans, C. W., Nebane-Akah, M., McKellip, S., Ananthan, S., Tower, N. A., Sosa, M., Rasmussen, L., White, E. L., Maki, B. E., Matharu, D. S., Golden, J. E., Aube, J., Brodsky, J. L., and Noah, J. W. (2012) High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity J. Biomol. Screen. 17, 194-203 10.1177/1087057111421630
56. Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., and Jans, D. A. (2012) Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus Biochem. J. 443, 851-856 10.1042/BJ20120150
57. Belon, C. A., High, Y. D., Lin, T. I., Pauwels, F., and Frick, D. N. (2010) Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor Biochemistry 49, 1822-1832 10.1021/bi901974a